Collagen shield treatment for corneal abrasions in the ER
Part of Brain & nervous system, Eyes & vision, Injuries & trauma clinical trials.
This trial tests whether a special collagen shield placed on the eye helps heal a scratch on the eye's surface (corneal abrasion) better than standard care. If you have a scratch on just one eye and are 18 or older, this study may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a scratch on just one eye (corneal abrasion).
- You are willing and able to sign a consent form and come back for follow-up visits.
- You are not allergic to certain antibiotics (like moxifloxacin) or pain relievers (like ibuprofen).
- You have not had certain eye problems or surgeries that could affect healing.
- You do not have any other serious eye conditions in the injured eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new clear gel patch that can be applied to corneal wounds (scars on the front of the eye) without needing stitches. The goal is to see if it helps heal corneal damage from injury or infection and is safe to use.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This trial tests a new eye drop to see if it can safely and effectively reduce corneal scars. It is for people who have a recent corneal injury (within the last month) that resulted in a scar that affects their vision.
This trial tests a new collagen implant for people with severe corneal melting that hasn't improved with standard treatments. The implant may help repair the cornea and prevent a hole from forming.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This study tests whether a special substance from stem cells (called secretome) can help heal chronic surface problems on the eye that haven't gotten better with standard treatments. It's for people with a stubborn scratch or defect on the cornea that has lasted more than 14 days.
Hear when a new Corneal Abrasions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.